BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37137225)

  • 1. Association between Nordic and Mediterranean diets with lipoprotein phenotype assessed by
    Rodríguez-Borjabad C; Narveud I; Christensen JJ; Ibarretxe D; Andreychuk N; Girona J; Torvik K; Folkedal G; Bogsrud MP; Retterstøl K; Plana N; Masana L; Holven KB
    Atherosclerosis; 2023 May; 373():38-45. PubMed ID: 37137225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary intake and lipid levels in Norwegian and Spanish children with familial hypercholesterolemia.
    Rodríguez-Borjabad C; Narveud I; Christensen JJ; Ulven SM; Malo AI; Ibarretxe D; Girona J; Torvik K; Bogsrud MP; Retterstøl K; Plana N; Masana L; Holven KB
    Nutr Metab Cardiovasc Dis; 2021 Apr; 31(4):1299-1307. PubMed ID: 33549456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein profile assessed by 2D-1H-NMR and subclinical atherosclerosis in children with familial hypercholesterolaemia.
    Rodríguez-Borjabad C; Ibarretxe D; Girona J; Ferré R; Feliu A; Amigó N; Guijarro E; Masana L; Plana N;
    Atherosclerosis; 2018 Mar; 270():117-122. PubMed ID: 29407879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mediterranean Dietary Treatment in Hyperlipidemic Children: Should It Be an Option?
    Massini G; Capra N; Buganza R; Nyffenegger A; de Sanctis L; Guardamagna O
    Nutrients; 2022 Mar; 14(7):. PubMed ID: 35405957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary counseling is associated with an improved lipid profile in children with familial hypercholesterolemia.
    Torvik K; Narverud I; Ottestad I; Svilaas A; Gran JM; Retterstøl K; Ellingvåg A; Strøm E; Ose L; Veierød MB; Holven KB
    Atherosclerosis; 2016 Sep; 252():21-27. PubMed ID: 27494447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.
    Torres AL; Moorjani S; Vohl MC; Gagné C; Lamarche B; Brun LD; Lupien PJ; Després JP
    Atherosclerosis; 1996 Sep; 126(1):163-71. PubMed ID: 8879444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive lipid and metabolite profiling of children with and without familial hypercholesterolemia: A cross-sectional study.
    Christensen JJ; Ulven SM; Retterstøl K; Narverud I; Bogsrud MP; Henriksen T; Bollerslev J; Halvorsen B; Aukrust P; Holven KB
    Atherosclerosis; 2017 Nov; 266():48-57. PubMed ID: 28963918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of dietary patterns and components with atherosclerosis risk biomarkers in familial hypercholesterolemia.
    Antoniazi L; Arroyo-Olivares R; Mata P; Santos RD
    Curr Opin Lipidol; 2022 Apr; 33(2):89-94. PubMed ID: 34907966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein profile assessed by 1H NMR, BMI and blood pressure are associated with vascular alterations in children with familial hypercholesterolaemia.
    Llop D; Feliu A; Ibarretxe D; Escribano J; Plana N; Borjabad-Rodríguez C; Masana L; Vallvé JC
    Nutr Metab Cardiovasc Dis; 2023 Oct; 33(10):2035-2043. PubMed ID: 37543518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of therapeutic lifestyle changes on lipid profiles assessed by NMR in children with familial and non-familial hypercholesterolemia.
    Rodríguez-Borjabad C; Malo AI; Ibarretxe D; Girona J; Heras M; Ferré R; Feliu A; Salvadó M; Varela A; Amigó N; Masana L; Plana N; ;
    Clin Investig Arterioscler; 2020; 32(2):49-58. PubMed ID: 32005605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to a Mediterranean diet, dyslipidemia and inflammation in familial hypercholesterolemia.
    Antoniazzi L; Arroyo-Olivares R; Bittencourt MS; Tada MT; Lima I; Jannes CE; Krieger JE; Pereira AC; Quintana-Navarro G; Muñiz-Grijalvo O; Díaz-Díaz JL; Alonso R; Mata P; Santos RD
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(7):2014-2022. PubMed ID: 34039501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternally inherited hypercholesterolemia does not modify the cardiovascular phenotype in familial hypercholesterolemia.
    Marco-Benedí V; Laclaustra M; Bea AM; Suarez-Tembra M; Plana N; Pinto X; Brea A; Sanchez-Hernandez RM; Civeira F
    Atherosclerosis; 2021 Mar; 320():47-52. PubMed ID: 33529866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Children with familial hypercholesterolemia display changes in LDL and HDL function: A cross-sectional study.
    Christensen JJ; Narverud I; Ruuth M; Heier M; Jauhiainen M; Ulven SM; Bogsrud MP; Kovanen PT; Halvorsen B; Oda MN; Wium C; Retterstøl K; Öörni K; Holven KB
    J Intern Med; 2021 Nov; 290(5):1083-1097. PubMed ID: 34506681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.
    Mattina A; Rosenbaum D; Bittar R; Bonnefont-Rousselot D; Noto D; Averna M; Bruckert E; Giral P
    Nutr Metab Cardiovasc Dis; 2018 May; 28(5):517-523. PubMed ID: 29525223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-density lipoprotein apheresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma inducible degrader of the LDLR, soluble low-density lipoprotein receptor, and proprotein convertase subtilisin/kexin type 9 levels as potential biomarkers of familial hypercholesterolemia in children.
    Girona J; Rodríguez-Borjabad C; Ibarretxe D; Heras M; Amigo N; Feliu A; Masana L; Plana N;
    J Clin Lipidol; 2018; 12(1):211-218. PubMed ID: 29102496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: Partial correction by low-density lipoprotein apheresis.
    Hussein H; Saheb S; Couturier M; Atassi M; Orsoni A; Carrié A; Therond P; Chantepie S; Robillard P; Bruckert E; Chapman MJ; Kontush A
    J Clin Lipidol; 2016; 10(1):124-33. PubMed ID: 26892129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal inheritance does not predict cholesterol levels in children with familial hypercholesterolemia.
    Narverud I; van Lennep JR; Christensen JJ; Versmissen J; Gran JM; Iversen PO; Aukrust P; Halvorsen B; Ueland T; Ulven SM; Ose L; Veierød MB; Sijbrands E; Retterstøl K; Holven KB
    Atherosclerosis; 2015 Nov; 243(1):155-60. PubMed ID: 26386212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid phenotype and heritage pattern in families with genetic hypercholesterolemia not related to LDLR, APOB, PCSK9, or APOE.
    Jarauta E; Pérez-Ruiz MR; Pérez-Calahorra S; Mateo-Gallego R; Cenarro A; Cofán M; Ros E; Civeira F; Tejedor MT
    J Clin Lipidol; 2016; 10(6):1397-1405.e2. PubMed ID: 27919357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.